big drug companies have decided to end their antibiotic research, including Roche Holding AG, Bristol-Myers Squibb Co and Eli Lilly & Co. AstraZeneca and GlaxoSmithKline -- and to a lesser extent Novartis AG, Merck & Co Inc and Pfizer Inc -- remain in...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to SPECIAL REPORT - When the drugs don't work
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account